John Laterra

4PUBLICATIONS
30CO-AUTHORS
Molecular targetsGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 17, 2026
Ivosidenib and Vorasidenib decrease intratumoral 2-hydroxyglutarate and total choline levels in patients with lower-grade glioma: an in vivo MR Spectroscopy study.

|Jul 26, 2023
Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma.

Bachchu Lal, Aditya Kulkarni, Joseph McDermott

|Jun 29, 2023
Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase-mutant Astrocytic and Oligodendroglial Tumors.

David Olayinka Kamson, Sushant Puri, Yingying Sang

|Apr 12, 2017
Neuro-Oncology: Current Concepts and Emerging Therapeutics.

Burt Nabors, John Laterra

Pageof 1

Frequent Collaborators

2 joint publications

David Olayinka Kamson

2 joint publications

Lindsay Blair

2 joint publications

Jaishri O Blakeley

1 joint publications

Sushant Puri